Gastrointestinal Stromal Tumor Diagnosis

Video

The clinical presentation that is typically observed with gastrointestinal stromal tumors (GISTs) is somewhat nonspecific, states Anthony P. Conley, MD. Patients may report symptoms related to anemia, such as fatigue and changes in skin color, usually in the chronic setting. GISTs can be detected through upper endoscopy or colonoscopy, notes Conley, but may escape detection because they tend to arise in the muscular layer rather than the epithelial portion of the gastrointestinal tract. Once GIST is suspected, it is important to conduct a biopsy to rule out other diseases, such as leiomyomas and leiomyosarcomas, comments Conley.

The majority of patients with GIST are asymptomatic, says Robert H. I. Andtbacka, MD, although they may present with abdominal discomfort and gastrointestinal bleeding. A GIST diagnosis is often discovered with CT scan of the abdomen, pelvis, and small bowel, explains Andtbacka. Colonoscopies also help confirm that the malignancy is not adenocarcinoma, which is more common in these locations than GIST, says Andtbacka.

Obtaining a core biopsy also allows for immunohistochemical staining for mast/stem cell growth factor receptor, also known as c-KIT (CD117), platelet derived growth factor receptor, and other receptors. Staining positive for these markers can also indicate a GIST diagnosis, as approximately 95% of GIST tumors express c-KIT.

Related Videos
Joachim G. J. V. Aerts, MD, PhD
Nathaniel Myall, MD
Martin Cannon, PhD, professor, Department of Microbiology, University of Arkansas for Medical Sciences College of Medicine
Pedro Barata, MD, MSc
In this fourth episode of OncChats: Examining LIFU–Aided Liquid Biopsy in Glioblastoma, Manmeet Singh Ahluwalia, MD, and Michael W. McDermott, MD, discuss the key objectives of the phase 3 LIMITLESS study (NCT05317858) examining low-intensity focused ultrasound with immunotherapy and chemotherapy in patients with lung cancer and brain metastases.
Brian Mitzman, MD, FACS, FCCP
Yvonne Chao, MD, PhD
Pradnya D. Patil, MD, FACP,
 In this third episode of OncChats: Traveling Through the Lung Cancer Treatment Paradigm, Aaron Franke, MD, discusses the expanding role of neoadjuvant therapy in non–small cell lung cancer and efforts to better identify patients who can benefit from curative-intent treatment.